A novel pre-clinical strategy to deliver antimicrobial doses of inhaled nitric oxide.
Effective treatment of respiratory infections continues to be a major challenge. In high doses (≥160 ppm), inhaled Nitric Oxide (iNO) has been shown to act as a broad-spectrum antimicrobial agent, including its efficacy in vitro for coronavirus family. However, the safety of prolonged in vivo implem...
Guardado en:
Autores principales: | Vinicius S Michaelsen, Rafaela V P Ribeiro, Edson Brambate, Aadil Ali, Aizhou Wang, Layla Pires, Mitsuaki Kawashima, Yu Zhang, Anajara Gazzalle, Shaf Keshavjee, Lorenzo Del Sorbo, Marcelo Cypel |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/be25913353d349a8a8fe74aa6e41fd90 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Inactivating hepatitis C virus in donor lungs using light therapies during normothermic ex vivo lung perfusion
por: Marcos Galasso, et al.
Publicado: (2019) -
EFFICACY OF SALBUTAMOL DELIVERED THROUGH A METERED DOSE INHALER & SPACER IN CHILDREN WITH ACUTE EXACERBATION OF ASTHMA
por: Ali Mujtaba Tahir, et al.
Publicado: (2021) -
Variability in delivered dose and respirable delivered dose from nebulizers: are current regulatory testing guidelines sufficient to produce meaningful information?
por: Hatley RHM, et al.
Publicado: (2017) -
Effects of inhaled nitric oxide on outcome after prolonged cardiac arrest in mild therapeutic hypothermia treated rats
por: Anne Brücken, et al.
Publicado: (2018) -
Inhaled Nitric Oxide in Patients with Severe COVID-19 Infection at Intensive Care Unit – A Cross Sectional Study
por: Herranz Laura, et al.
Publicado: (2021)